Transferrin (Tf) plays an important role during immunologic activation by donating iron to activated lymphocytes. Therefore, synthesis by lymphomyeloid cells has been investigated. Mouse macrophages and macrophage cell lines synthesized Tf, with levels being markedly increased by yinterferon (y-IFN) and, to a lesser extent, by interleukin-lp (IL-Ifi), IL-6, and tumor necrosis factor a (TNFa). Tf was also produced by phytohemagglutinin-stimulated human T cells and two T-cell lines and was increased by IL-2. Even after appropriate activation, none was synthesized by human macrophages or monocytic cell lines or by mouse T cells, Tcell lines, or thymus cells. In both species, B-lineage cell lines were negative. Tf was also synthesised by macrophages HE PLASMA IRON-BINDING protein transferrin (TO plays a number of important roles in the immune system. Proliferation of both and B'.' lymphocytes, after stimulation with antigen, mitogens, andlor cytokines, does not proceed optimally in the absence of Tf, and this protein is required for in vitro production of IgE by B cells.' It has also been shown to enhance natural killer cell a~tivity,~ modulate neutrophil adhesiveness,6 and help prevent experimental allograft rejection. ' In most cases Tf fulfills these functions through its ability to act as an iron transport protein.' In particular, the ability of Tf to promote lymphocyte proliferation depends on the delivery of iron via expression of Tf receptors on activated lymphocytes: which permits endocytosis of Tf and intracellular delivery of iron." As a result, the ability of Tf to enhance lymphocyte proliferation is related to the degree of iron saturation of the protein."."
by in vivo activation and that the released Tf contained iron and can support lymphocyte proliferation.20 These observations support the proposal that Tf synthesized by lymphomyeloid cells could be of importance in activating the immune system.
Lymphocyte activation is a complex process in which cytokines play a key role (notably interleukin-2 [IL-21 in the case of T cells and IL-4 and IL-5 for B cells), and activation of macrophages depends on the cytokine y-interferon ( y -IFN). If Tf synthesized by lymphomyeloid cells is important in their activation, then it seems likely that this too would be regulated by cytokines. However, apart from some preliminary evidence that y-IFN can upregulate macrophage Tf synthesis,2' nothing is known about the regulation of Tf synthesis in lymphomyeloid cells.
Therefore, in this study, we have investigated the ability of human and murine macrophages, T cells, and B cells to synthesize Tf, have determined whether cytokines critical for the activation of these cells can also regulate Tf synthesis, and have compared the results with those obtained with hepatic cells.
MATERIALS AND METHODS

Materials
Proteins and cell activators. Mouse IL-I@ and IL-6 were obtained from British Biotechnology (Oxford, UK). Human IL-2 and concanavalin A were obtained from Sigma (Poole, UK). Phytohemagglutinin (PHA) was obtained from Wellcome (Beckenham, UK). Lipopolysaccharide (LPS) was obtained from Difco (Detroit, MI). Phorbol myristate acetate (PMA) and human y-IFN were provided by Dr C. McSharry, and all other cytokines by Dr A. Severn (Department of Immunology, University of Glasgow). Contamination with endotoxin did not exceed 0.1 ng/pg of cytokine. For all cytokines, dose-response curves were performed in preliminary experiments.
All assays were performed using cytokines of the homologous species except in the case of transforming growth factor @ (TGFP), which was of bovine origin.
Human Tf was obtained from Behringwerke (Hounslow, UK), and mouse Tf from Chemicon International (London, UK). Polyclonal antisera to Tfs were raised in rabbits, and, in addition, a polyclonal sheep antiserum to human Tf was obtained from the Scottish Antibody Production Unit (Lanark, UK).
Ferric nitrilotriacetate (FeNTA), a chelate that maintains Fe'+ in 
Cells and Cell Culture
Except where otherwise stated, all cells were routinely cultured in RPMI 1640 medium (Flow-ICN, Rickmansworth, UK) containing 10% fetal calf serum (Flow). Cells were extracted from primary tissues and were purified and/or activated, as was appropriate, as described below, before assaying for Tf synthesis by immunoprecipitation and enzyme-linked immunosorbent assay (ELISA), as described in the section on Tf synthesis. Log-phase cultures of cell lines were washed and then treated similarly.
Murine peritoneal and alveolar macrophages were obtained from normal Balb/C or outbred BKTO mice or mice that had been injected intraperitoneally 4 days previously with 2 mL of thioglycolate broth (Difco) to yield elicited macrophages or with 2 mg of Corynebacrerium parvum (provided by Prof P.C. Wilkinson, Department of Immunology, University of Glasgow) to yield activated macrophages (no differences were observed between mouse strains). Mouse lymph node macrophages were isolated from in vivo-stimulated lymph nodes as described previously.2" Human peritoneal macrophages were obtained as described previously2' from end-stage renal failure patients undergoing continuous ambulatory peritoneal dialysis and from healthy women undergoing laparoscopy. Human alveolar macrophages were obtained by bronchoalveolar lavage of patients without inflammatory lung disease. Adherent cultures were obtained by removing nonadherent cells after 2 hours of incubation. All human samples were obtained during procedures performed during the clinical management of the patients.
Murine lymphocytes stimulated in vitro with concanavalin A were prepared from lymph nodes as described previously.' The efficacy of stimulation was checked by measuring tritiated thymidine incorporation. PHA-stimulated human peripheral blood lymphocytes were obtained m described previously.'' Thymus cells were obtained from 18-day fetuses by gently teasing out the thymus into RPMI-1640 medium. After leaving the tissue debris to settle, the cell suspension was carefully aspirated and washed before use.
The following cell lines were also tested for Tf synthesis: DIO, a cloned mouse T-cell line; EL4, a mouse thymoma; X63, a mouse plasmacytoma; the murine monocytehacrophage cell lines P388DI and J774; M059, a mouse macrophage hybridoma24; BWT G2, a mouse hepatoma; Jurkat, a human T-cell line; CCRF-CEM, a human T-leukemic cell line; Raji, a human B-cell line; U937. a human promonocytic line; THPI, a human monocytic leukemia cell line; and the human hepatoma, Hep G2. 
Hypotransferrinemic Mice
Alveolar and peritoneal macrophages were obtained from heterozygote (hpx/+) and homozygote (hpxhpx) hypotransfemnemic mice. These mice carry an autosomal recessive defect in Tf production, and the homozygotes contain almost no Tf in their serum."
Tf Synthesis
Immunoprecipitation. This was performed using metabolic labeling with ['%]-cysteine, as described previously?" Controls containing an excess of unlabelled Tf (competition) and normal rabbit serum instead of antitransfenin were always included to check for specificity.
Quantification ofTfby ELISA. Cells were cultured for 18 hours in serum-free RPMI 1640 medium with appropriate additions, and the supernatant was obtained. In some cases, the cells were also recovered, and RNA was extracted to allow parallel quantification of Tf mRNA levels using slot-blotting (see below). ELISA assays were developed to quantify mouse and human Tf in cell culture supernatants. For mouse Tf, microtiter plates (Immulon; Dynatech, Billingshurst, UK) were coated with rabbit antimouse Tf, and detection was performed using the same antibody after conjugation to alkaline phosphatase (Sigma). For human Tf, plates were coated with sheep antihuman Tf, and alkaline phosphatase-conjugated sheep antihuman Tf (Serotec. Kidlington. UK) was used for detection.
Detection and quantification of Tf mRNA. Total cellular RNA was extracted by lysing the cells (cultured as for ELISA assays) or by homogenizing tissues in RNAzol B (Biogenesis, Bournemouth, UK). Tf mRNA was detected by Northern blotting, as described previously,'" using a '2P-labeled cDNA probe to human Tf (provided by Dr B.H. Bowman, Department of Cellular and Structural Biology, University of Texas Health Science Center, San Antonio, TX) that is known to hybridize readily with both human and mouse Tf mRNA, giving a single band at approximately 2.3 kb.Iy Relative levels of Tf mRNA were measured by slot-blotting, and an oligonucleotide probe to total ribosomal RNA (synthesized in the Department of Biochemistry, University of Glasgow, UK) was used as control. The hybridization signals were quantified by densitometry using preflashed film.
RESULTS
Tf Synthesis by Lymphomyeloid Cells
Synthesis of Tf by the various primary cell cultures and cell lines and the presence of Tf mRNA were examined by immunoprecipitation and Northern blotting, respectively. As reported previously,2" the immunoprecipitation method gave a single radioactive band with a molecular weight ( M,) of 78 kD corresponding to Tf, and a Northern blot is shown in Fig 1. The results are summarized in Table 1 . All the murine macrophages and macrophagehonocyte cell lines synthesized Tf, but none was produced by murine T lymphocytes or lymphocytic cell lines. Furthermore, no Tf synthesis could be detected by immunoprecipitation in the thymus cells of 18-day mouse fetuses, the time when maximum development of T-cell function occurs. In contrast to murine cells, no Tf protein or mRNA could be detected in human macrophages 
Lymphoid cells
(see Materials and Methods for details).
or monocytic cell lines. However, Tf synthesis did occur in PHA-stimulated human T cells and in the two T-cell lines Jurkat and CCRF-CEM. The murine plasmacytoma X63 and the human B-cell line Raji were both negative.
Effect of Cytokines and Other Stimuli on Tf Synthesis by Lymphomyeloid Cells
Because some but not all of the lymphomyeloid cells examined clearly synthesized TF, it was of interest to determine whether cytokines or other cell activators could modulate synthesis and whether they could induce Tf synthesis in cells that were previously negative. This was performed by determining Tf levels in culture supernatants by ELISA.
Unstimulated mouse resident peritoneal macrophages produced about 25 ng Tf/106 cells over the 18-hour incubation period (Fig 2) . However, Tf production was markedly stimulated, to 300 to 400 ng/106 cells, by y-IFW, PMA, and LPS (Fig 2) . IL-I and tumor necrosis factor cy (TNFa) had a lesser but still quite marked effect, and IL-6 produced a more modest fourfold increase. Iron (100 pmoVL) in the form of FeNTA had no effect on Tf production.
In mouse macrophages stimulated in vivo by thioglycolate broth, the background level of Tf production was about double that of resident macrophages (Fig 3) . As with the resident cells, y-IFN, LPS, and PMA all enhanced Tf production, although the amounts were no greater, and in some cases somewhat less, than those produced by activation of the resident macrophages. However, unlike resident macrophages IL-l, IL-6, and TNFa caused no increase in Tf levels. Again, FeNTA was without effect as were also TGFP, IL-4, and IL-5. These last three cytokines did not affect the stimulatory effect of y-IFN when tested in combination (data not shown).
The effect of cytokines and other agents on Tf synthesis by mouse alveolar macrophages was very similar to that observed with elicited peritoneal macrophages (Fig 4) , although the baseline level of synthesis was even higher, about 85 ng/106 cells. This finding is in agreement with the idea that alveolar macrophages tend to be more highly activated than resident peritoneal macrophages. For No Tf could be detected by ELISA in culture supernatants of normal human alveolar macrophages (<2 ng/106 cells), which is in agreement with the results of immunoprecipitation shown in Table 1 . Treatment with PMA, LPS, or y-IFN failed to induce detectable levels of Tf production. Similarly, preincubation of the murine plasmacytoma X63 with IL-4 or IL-5 failed to induce detectable levels of Tf in culture supernatants.
The amount of Tf synthesized by unstimulated Jurkat cells was lower than that produced by mouse macrophages, about 10 ng/106 cells (Fig 5) . Nevertheless, synthesis was strongly enhanced by human IL-2, and PHA caused a lesser but still marked increase in Tf synthesis. Combination of the two had an additive effect. y-IFN and IL-1 had a much more modest enhancing effect, and IL-6 and FeNTA had none.
Tf Synthesis by Hepatoma Lines
A completely different pattern of stimulation of Tf synthesis was observed with hepatoma cell lines. Base levels were at least 10-fold greater than in any of the lymphomyeloid cells, both in the murine BWT G2 line (Fig 6A) and the human hepatoma Hep G2 (Fig 6B) . Whereas IL-6 caused an appreciable increase ( Figs 6A and B) , other cytokines, ie, y-IFN, IL-l, and TNFa, had no effect. Furthermore iron, which was without effect on Tf production by the lymphomyeloid cells, had a dose-dependent inhibitory effect on Tf synthesis by the murine BWT G2 hepatoma cells (Fig 6C) . The effect of iron on the human hepatoma cell line Hep G2 was very similar (data not shown).
Effect of Cytokines and Iron on Tf mRNA Levels
To determine whether the changes in Tf production caused by cytokines or iron occurred at the translational or pretranslational level, Tf mRNA levels in mouse macrophages, in the human T-cell line Jurkat, and in the mouse hepatoma BWT G2 were quantified by slot-blotting before or after Values are expressed relative to control cultures (equal to 100) without cytokines or iron. Results are mean of duplicate determinations that did not differ by more than 17% from the mean.
Abbreviation: N/T, not tested.
incubation with appropriate cytokines or iron. Treatment of mouse resident peritoneal macrophages with y-IFN increased Tf mRNA levels threefold (Table 2) , whereas treatment of the cells with 100 p m o K Fe had no appreciable effect. Similarly, treatment of Jurkat cells with IL-2 caused a fourfold increase in Tf &A, whereas iron again had no effect. On the other hand, treatment of BWT G2 cells with 100 pmol/L Fe decreased Tf mRNA levels by half, whereas IL-6 caused a twofold increase. Therefore, Tf mRNA levels broadly paralleled protein production.
Tf Synthesis by Hypotransferrinemic Mouse Macrophages
Because the preceding experiments showed a clear difference between the regulation of Tf synthesis in lymphomyeloid cells and in hepatoma cells, it was of interest to examine whether macrophages from congenitally hypotransferrinemic mice, in which there is virtually no hepatic Tf synthesi s: ' could produce Tf. Both resident peritoneal and alveolar macrophages from the homozygotes (hpxlhpx) synthesized detectable amounts of Tf, although levels were only about 25% of those produced by corresponding cell populations from normal Balb/C mice (Table 3) . Macrophages from heterozygote (hpx/+) hypotransferrinemic mice gave levels of synthesis similar to those in normal mice. In all the mice, treatment with y-IFN markedly upregulated Tf synthesis, although levels produced by homozygotes were only about 10% of those from y-IFW-stimulated control cells.
DISCUSSION
In a previous study, we showed that mouse macrophages synthesize Tf and that the released Tf contained iron and was able to promote proliferation of mitogen-stimulated murine T cells." Therefore, it was suggested that Tf synthesized by macrophages could act in a paracrine manner to provide iron to activated lymphocytes, which is required for proliferation.* As suggested in our previous study,*' this would allow lymphocyte proliferation to proceed optimally despite the reduction in plasma Tf levels and iron saturation that normally accompany immunologic or inflammatory activation.I3
The present study has extended these findings and clearly shows that Tf synthesis by mouse macrophages is regulated by cytokines, thus providing an immunologic means of regulating Tf levels in lymphomyeloid tissues. The greatest enhancement in all the macrophages examined was caused by y-IFN, which is produced by activated T cells and is the cytokine principally responsible for macrophage activation. LPS and PMA, which also activate macrophages, similarly induced a marked increase in Tf synthesis. Cytokines associated with an inflammatory response, such as IL-1, IL-6, and TNFa, produced a more modest increase in Tf synthesis by resident mouse peritoneal macrophages but had no effect on the higher base levels produced by alveolar macrophages or thioglycolate-elicited peritoneal macrophages, suggesting that in these cells enhancement of Tf synthesis by inflammatory stimuli had already occurred in vivo. It is of interest that TGFP, which activates monocyte/macrophages but suppresses T-cell a~tivation,'~ did not enhance Tf production. IL-4, which suppresses the production of inflammatory mediators by macrophages,*' had no effect on Tf synthesis by in vivo-stimulated macrophages, and the same was true of IL-5, which acts primarily on B cells.
It is evident that synthesis of Tf by macrophages is regulated quite differently from that in hepatic cells. y-IFN, IL-I, and TNFa were all without any enhancing effect on hepatic Tf synthesis, and only IL-6, which is well known to stimulate hepatocytes, caused any enhancement in Tf production. In contrast, iron downregulated synthesis by hepatocytes, which is consistent with the increase in Tf levels observed in iron-deficient individual^,'^ but had no effect on synthesis by macrophages. This suggests that Tf synthesis by macrophages is related to needs arising from immunologic and inflammatory responses rather than to overall iron status. Tf synthesis in other nonhepatic tissues in which a local function has been proposed, such as the mammary glandz9 and the te~tis,~" also appears to be regulated differently from hepatic synthesis and is similarly insensitive to iron.
Further evidence for differences in the regulation of Tf synthesis in hepatic and lymphomyeloid cells comes from the results obtained using macrophages from congenitally hypotransfemnemic (hpx) mice. Although synthesis of Tf by the liver of these animals is almost nonexistent:' surprisingly the peritoneal macrophages did produce detectable levels of Tf, albeit lower than in controls or heterozygotes. This appears to be the first clear evidence that some tissues of hpx mice are capable of Tf synthesis. It is of interest that Tf synthesis by macrophages from the heterozygote (hpd -) mice was similar to that in normal controls, because hepatic synthesis in the heterozygotes is only about 50% of For personal use only. on August 30, 2017 . by guest www.bloodjournal.org From that in ~o n t r o l s .~'~~~ Moreover, as in normal mice, synthesis by macrophages from the homozygotes was responsive to y-IFN. Therefore, the abnormality, which appears to be caused by a splicing defect that prevents translation of the ZIRNA,~~ is evidently less critical to macrophages than to hepatocytes. These findings may explain why hypotransfemnemic mice show a marked suppression of erythropoiesis but apparently do not suffer from any obvious immunologic abnormalities. Therefore, the hpx mouse may provide a useful model for further elucidating how regulation of Tf synthesis differs between lymphomyeloid and hepatic cells.
The results obtained with mouse cells are consistent with the proposal that Tf produced within lymphoid tissues by macrophages may act in a paracrine manner to promote lymphocyte proliferation. However, it is evident from the results obtained using human cells that, whereas a comparable mechanism may operate in humans, it must do so in a somewhat different way. In the mouse, Tf synthesis was detected in all monocytic/macrophage cells examined, whereas primary human macrophage cultures and monocytic cell lines were consistently negative, and even stimulation with y-IFN failed to induce synthesis of detectable levels of Tf. In contrast, human T cells, both primary cultures and cell lines, synthesized Tf in contrast to the corresponding murine cells. Therefore, in humans, Tf may act on activated T cells in an autocrine rather than a paracrine manner, as suggested previously by Lum et aLL5 IL-2, which plays a key role in T-cell activation, was the most effective of the cytokines tested in stimulating Tf production by the human T-cell line Jurkat. PHA also markedly enhanced Tf production by a mechanism that appears to be independent of IL-2 production, because IL-2 plus PHA produced an additive effect. A small increase in Tf synthesis also occurred in the presence of IL-l, IL-6, and y-IFN, but as with mouse macrophages, iron had no effect. Therefore, as with murine macrophages, Tf synthesis by human T cells is upregulated most effectively by a cytokine that plays a key role in activation.
Although Tf enhances proliferation of human T cells,'323i' some reports suggest that non-Tf-bound forms of iron are also e f f e~t i v e .~~-~~ Because human T cells synthesize Tf, and this is upregulated by PHA, it seems possible that Tf synthesized by the T cells themselves might mediate the effect of non-Tf iron, because anti-Tf receptor antibodies could inhibit proliferation even in the absence of exogenous Tf. 35 In both mice and humans, cells of B lineage did not synthesize Tf. This is in agreement with the findings of Seligman et al, 37 who suggested that B cells may use a Tf-independent mechanism for acquisition of iron. Nevertheless, other studies have shown that Tf can enhance the proliferation of both human3 and murine' B cells, and it seems likely that, in vivo, activated B cells could use Tf synthesized by nearby macrophages or T cells as a paracrine growth factor.
Although a more exhaustive study of different tissues and cell lines would be needed to unambiguously establish the apparent species variation in lymphomyeloid Tf synthesis reported here, earlier work also supports the existence of such a difference. Previous reports of Tf synthesis by macrophages have all referred to cells of rodent rig in,'"'^ whereas studies of Tf synthesis by T cells have referred to hum a n~. '~, '~ In one apparently contradictory study, Wesselius et a13* reported the presence of Tf in human alveolar macrophages, but their results do not exclude the possibility that this was of exogenous origin, perhaps acquired as a result of endocytosis via Tf receptors. Such an explanation is unlikely to account for the present results, because Tf synthesis was determined by metabolic labeling as well as by ELISA, and an endocytic origin would be difficult to reconcile with the species difference observed here.
In all instances examined, synthesis of Tf protein was paralleled by the presence and/or levels of mRNA, as determined by Northern blotting and slot-blotting, suggesting that regulation occurred at a pretranslational level. In particular, cytokine stimulation failed to induce Tf protein or mRNA in those cells that were completely negative in the resting state. The molecular mechanisms regulating Tf synthesis are complex and not fully understood. Synthesis in the liver and testis is thought to be transcriptionally regulated, but with different factor(s) regulating transcription in each tissue. 30 It seems likely that a further set of transcription factors that are responsive to cytokines are involved in Tf synthesis by lymphomyeloid cells. Further studies will be required to identify the various factors involved.
In conclusion, we have shown that, depending on the species, lymphocytes or macrophages are capable of synthesising Tf and that such synthesis can be regulated by immunologic stimuli. This, together with our previous observation that macrophage-derived Tf contains iron, provides support for the proposal that Tf produced within lymphoid tissues may have an immunoregulatory function. In humans, Tf produced by T cells could function in an autocrine manner, as previously suggested by Lum et al," whereas in the mouse, macrophage-derived Tf could act in a paracrine manner on activated lymphocytes. It has been shown that mouse Thl clones are more susceptible than Th2 clones to iron deprivat i~n ,~~ and regulation of iron supply from locally-synthesized Tf could provide a means of "fine-tuning" the immune system through differential activation of lymphocyte subsets. For personal use only. on August 30, 2017 . by guest www.bloodjournal.org From
